In a surprising number of Australian mid-market firms, ‘innovation strategy’ is approved in the same week as the annual budget and quietly dismantled by the second forecast. Nobody votes to kill it. Cash simply migrates back to known work when a wet winter, a delayed tender, or a dividend conversation arrives.
The pattern is easy to miss because the language stays generous. Steering committees still meet. The lab still has a name. What disappears is the envelope: the unglamorous line that said this bet may spend until March even if EBITDA is noisy.
July is a mood. November is a ledger.
Boards are not villains. They are responding to thin capital markets and to lenders who do not grade you on option value. If your mandate never named a floor — a cash amount that is protected unless a kill criterion is hit — then you never had a strategy. You had a seasonal enthusiasm.
Fileflowbase asks a crude question in the Mandate Studio: what happens to this bet if the second-quarter forecast is ugly? If the answer is ‘we pause’, write that down as the actual policy. Pausing is sometimes correct. Pretending you will not pause is how you waste the first five months of salary.
Protect a small envelope or do not start
A protected envelope is not a blank cheque. It is a published number with an owner and a stop rule. When November comes, the conversation is whether a kill criterion fired, not whether the idea still feels modern.
If your finance committee cannot live with even a modest protected envelope, do not hire a studio. Hire a cost programme. That is honest work. It is different work.